Cas12a

Seamless gene editing

CRISPR-Cas12a can induce and track changes in a variety of immune system cells in response to gene editing and fine-tune sets of genes in different directions simultaneously.

New CRISPR tool enables more seamless gene editing — and improved disease modeling

Yale scientists have developed a CRISPR technology that can assess genetic interactions on a host of immunological responses to multiple diseases, including cancer.

https://news.yale.edu/2025/03/20/new-crispr-tool-enables-more-seamless-gene-editing-and-improved-disease-modeling

Cas12a

Seamless gene editing

Recommendations